- Home
- NHTC vs IFRX Comparison
NHTC vs IFRX Comparison
Compare NHTC & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHTC
- IFRX
- Stock Information
- Founded
- NHTC 1988
- IFRX 2007
- Country
- NHTC United States
- IFRX Germany
- Employees
- NHTC N/A
- IFRX N/A
- Industry
- NHTC Diversified Commercial Services
- IFRX Biotechnology: Pharmaceutical Preparations
- Sector
- NHTC Miscellaneous
- IFRX Health Care
- Exchange
- NHTC Nasdaq
- IFRX Nasdaq
- Market Cap
- NHTC 56.0M
- IFRX 53.5M
- IPO Year
- NHTC 1995
- IFRX 2017
- Fundamental
- Price
- NHTC $4.43
- IFRX $1.37
- Analyst Decision
- NHTC
- IFRX Strong Buy
- Analyst Count
- NHTC 0
- IFRX 5
- Target Price
- NHTC N/A
- IFRX $7.40
- AVG Volume (30 Days)
- NHTC 30.8K
- IFRX 504.3K
- Earning Date
- NHTC 10-29-2025
- IFRX 11-07-2025
- Dividend Yield
- NHTC 18.06%
- IFRX N/A
- EPS Growth
- NHTC N/A
- IFRX N/A
- EPS
- NHTC 0.03
- IFRX N/A
- Revenue
- NHTC $42,087,000.00
- IFRX $191,224.00
- Revenue This Year
- NHTC N/A
- IFRX N/A
- Revenue Next Year
- NHTC N/A
- IFRX $1,216.24
- P/E Ratio
- NHTC $149.67
- IFRX N/A
- Revenue Growth
- NHTC N/A
- IFRX 54.36
- 52 Week Low
- NHTC $4.02
- IFRX $0.71
- 52 Week High
- NHTC $6.79
- IFRX $2.82
- Technical
- Relative Strength Index (RSI)
- NHTC 49.01
- IFRX 53.09
- Support Level
- NHTC $4.30
- IFRX $1.14
- Resistance Level
- NHTC $4.68
- IFRX $1.44
- Average True Range (ATR)
- NHTC 0.20
- IFRX 0.15
- MACD
- NHTC 0.01
- IFRX -0.02
- Stochastic Oscillator
- NHTC 42.21
- IFRX 47.00
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.